|
| Smoking cessation drug Chantix must have mental health warning |
1 Jul 09, 17:22 |
|
| New York -- The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts. |
| more |
|
